Side effects of rhabdomyolysis
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Rhabdomyolysis
Introduction to Rhabdomyolysis
Rhabdomyolysis is a serious medical condition characterized by the breakdown of muscle tissue, leading to the release of muscle fiber contents into the bloodstream. This can result in a range of complications, some of which can be life-threatening. The condition can be triggered by various factors, including drug interactions, physical exertion, infections, and more .
Acute Kidney Injury (AKI)
One of the most severe complications of rhabdomyolysis is acute kidney injury (AKI). This occurs due to the toxic effects of myoglobin, a muscle protein released into the bloodstream, which can cause renal vasoconstriction, ischemia, and direct toxicity to the renal tubular cells . AKI is observed in approximately 33% of rhabdomyolysis cases and is a significant cause of morbidity and mortality .
Electrolyte Imbalances
Rhabdomyolysis can lead to several electrolyte disturbances, including hyperkalemia, which can cause cardiac arrhythmias, metabolic acidosis, hyperphosphatemia, early hypocalcemia, and late hypercalcemia . These imbalances are due to the release of intracellular contents from damaged muscle cells into the bloodstream.
Myoglobinuria
The presence of myoglobin in the urine, known as myoglobinuria, is a hallmark of rhabdomyolysis. This can lead to dark, tea-colored urine and is a sign of muscle breakdown. Myoglobinuria contributes to the development of AKI by forming casts in the renal tubules and exerting a direct toxic effect on renal cells .
Compartment Syndrome
Compartment syndrome is another serious complication of rhabdomyolysis. It occurs when increased pressure within a muscle compartment reduces blood flow, leading to muscle and nerve damage. This condition requires prompt diagnosis and treatment, often necessitating surgical intervention such as fasciotomy to relieve the pressure.
Disseminated Intravascular Coagulation (DIC)
Disseminated intravascular coagulation (DIC) is a rare but severe complication of rhabdomyolysis. It involves widespread clotting and bleeding throughout the body, which can be life-threatening. DIC is triggered by the release of pro-coagulant substances from damaged muscle cells .
Drug Interactions and Rhabdomyolysis
Certain medications, particularly statins, are known to increase the risk of rhabdomyolysis. The risk is heightened when statins are used in combination with other drugs such as cyclosporine, gemfibrozil, and ciprofloxacin, which can interfere with their metabolism and increase their blood levels . For instance, the concomitant use of simvastatin and cyclosporine has been reported to cause severe rhabdomyolysis and subsequent AKI.
Conclusion
Rhabdomyolysis is a complex condition with a range of potential complications, including acute kidney injury, electrolyte imbalances, myoglobinuria, compartment syndrome, and disseminated intravascular coagulation. Prompt recognition and treatment are crucial to prevent severe outcomes. Clinicians should be aware of the potential drug interactions that can precipitate rhabdomyolysis and monitor patients accordingly.
Sources and full results
Most relevant research papers on this topic